Table of Contents

A patent infringement analysis Cambridge companies can rely on has to bridge two places at once, because Cambridge is where the technology and the patents are made but London is where the disputes are actually tried. The city sits at the centre of “Silicon Fen”, one of Europe’s deepest clusters of deep-tech, semiconductor and life-sciences innovation, with more than 5,000 knowledge-intensive companies and a stream of university spin-outs behind Arm, AstraZeneca and a generation of start-ups.
There is no patent court in Cambridge itself. UK patent infringement is heard in London, in the Patents Court and the Intellectual Property Enterprise Court, and — crucially — the United Kingdom sits outside the Unified Patent Court and the EU unitary patent. A Cambridge business enforcing or defending a patent therefore needs an analysis built for the English courts and the UK’s own strategic position. PerspireIP builds that analysis for the counsel who represent them.
Where a patent infringement analysis Cambridge case is heard
Although the invention usually happens in Cambridge, the litigation happens in London. Patent infringement in England and Wales is heard by the Patents Court, part of the Business and Property Courts of the High Court, sitting at the Rolls Building on Fetter Lane, or by the Intellectual Property Enterprise Court (IPEC) in the same building. A Cambridge company that sues, or is sued, will find itself in one of these two London courts rather than in any local venue.
The Patents Court is the senior forum, staffed by specialist patents judges who hear the largest and most technical disputes. IPEC is designed for smaller and simpler cases, with capped costs and a streamlined procedure that makes it accessible to start-ups and SMEs — exactly the kind of company Silicon Fen produces. Appeals from either court go to the Court of Appeal and, ultimately, to the UK Supreme Court.
- Patents Court (Rolls Building, London) — the High Court forum for larger, more technical patent disputes
- IPEC (Rolls Building, London) — the cost-capped court for smaller and simpler claims
- Court of Appeal — hears appeals from the Patents Court and IPEC
- UK Supreme Court — the final court of appeal on points of law
Unlike the German system, the English courts do not bifurcate: infringement and validity are decided together in a single trial before one judge. That means a patent infringement analysis Cambridge counsel commission has to address non-infringement and invalidity side by side from the very start of the case.
The UK is outside the UPC: a key strategic split
The single most important strategic fact for a Cambridge business is that the United Kingdom is outside the Unified Patent Court and the EU unitary patent system. After Brexit, the UK did not join the UPC, so a European patent’s UK designation is litigated only in the English courts — entirely separately from any parallel UPC action covering the participating EU member states.
For a Cambridge company with markets across Europe, that creates two distinct battlegrounds. The same underlying European patent may be enforced against it in the UPC for the continental designations and in the London Patents Court for the UK designation, on different timetables, under different procedures, and with the possibility of different outcomes. A UK win does not bind the UPC, and a UPC decision does not bind the English court.
- The UK national designation of a European patent is litigated only in the English courts
- UPC judgments do not cover the UK, and English judgments do not cover UPC states
- A dispute can run in parallel in London and before the UPC with separate outcomes
- Forum, timing and evidence strategy have to be coordinated across both systems
This split is an opportunity as much as a risk. A well-run UK case can secure an outcome independent of the UPC, and a strong invalidity or non-infringement position in London can shape the wider European dispute. The first job in any patent infringement analysis Cambridge engagement is to map which rights are in play in which forum.
IPEC or the Patents Court? Choosing venue by value and complexity
One of the sharpest choices a Cambridge litigant faces is between the two London courts. The Patents Court handles the heaviest, highest-value and most technically complex disputes with no ceiling on damages or costs. IPEC is deliberately constrained: on its multi-track, damages are capped at £500,000 and recoverable costs are capped — historically at £50,000 for a liability trial — with a streamlined, shorter procedure.
For a spin-out or SME, that cost cap can be the difference between being able to enforce a patent and being priced out of court altogether. IPEC lets a smaller Cambridge company litigate with predictable exposure, while a scale-up defending a bet-the-company semiconductor or biotech patent may need the Patents Court’s full procedure. The right choice depends on the value at stake, the technical complexity and how much disclosure and expert evidence the case really needs.
That venue decision feeds straight back into the analysis. An IPEC case rewards a tight, focused infringement and invalidity read that can be tried in a day or two, while a Patents Court case can support a fuller, more granular technical record. We scope the depth of the claim charts and prior-art search to the forum, so the work matches the procedure the case will actually run under.
Silicon Fen: the deep-tech and biotech claims that get litigated
The Cambridge cluster is unusually concentrated in exactly the technologies that generate hard-fought patent disputes. Semiconductors and processor architecture — the field Arm grew out of — produce standard-essential and complex electronics claims. Life sciences and biotech, anchored by AstraZeneca and a dense biomedical base, produce antibody, formulation and diagnostic claims. Add software, AI and connectivity spun out of the University of Cambridge, and the local docket is heavily deep-tech.
Each of these hides its infringement questions in a different place. Semiconductor and standards claims turn on mapping the asserted claim to a technical standard or to silicon-level implementation. Biotech and pharmaceutical claims often turn on non-patent literature, sequence data and functional or Markush language. Software and AI claims turn on how a system actually behaves at runtime. A credible infringement read has to be built by someone who understands the specific technology, not by a generic keyword pass.
- Semiconductor, processor and standard-essential electronics claims
- Antibody, formulation, diagnostic and other life-sciences and biotech claims
- Software, AI and connectivity claims from university spin-outs
- University and start-up patents where inventorship and priority dating matter
Because so many Cambridge patents originate in university research, the paper trail behind them — theses, journal articles, conference talks and grant disclosures — is often central to both infringement dating and any invalidity defense.
Claim charts and evidence of use for a Cambridge assertion
The core deliverable in an English patent case is a claim chart that maps every element of the asserted claim onto the accused product or process, backed by evidence a Patents Court or IPEC judge can test. Because the English courts decide infringement and validity together, a patent infringement analysis Cambridge counsel can rely on has to build both reads on the same claim construction from the outset.
- Claim construction fixing the meaning of each disputed term under English purposive-construction principles
- Element-by-element charts mapping each integer of the claim to the accused product
- Evidence of use — teardowns, product and technical documentation, source or configuration data and standards references
- Analysis of both normal infringement and infringement under the doctrine of equivalents recognised in UK law
- A parallel invalidity read, since validity is tried alongside infringement in the same proceeding
For semiconductor and standards claims the evidence of use often runs through a technical standard or a silicon teardown; for biotech claims it runs through laboratory characterisation, sequence comparison and the scientific literature. In every case the chart is written so a specialist English patents judge can follow the mapping element by element without gaps, and so it stands up to cross-examination of the expert witnesses at trial.
Coordinating UK and UPC strategy for a Cambridge company
Because the UK is outside the UPC, a Cambridge business with European markets frequently has to fight, or plan for, two parallel disputes. The UK designation of a European patent is litigated in London; the unitary or non-opted-out designations are litigated before the UPC. The two systems have different procedures, different disclosure regimes and different timetables, and they can reach different conclusions on the same technology.
That makes coordination essential. A claim construction or invalidity argument advanced in London should be consistent with the position taken before the UPC, even though neither court binds the other, because inconsistent stories are exposed quickly when both cases are running. Equally, an early UK judgment can create useful momentum, and a strong UK invalidity position can influence settlement across the whole European dispute.
We build the UK infringement and invalidity analysis with that wider picture in mind, so it slots cleanly alongside whatever is happening at the UPC. For an in-house team at a Cambridge scale-up, having one coherent technical story across both systems is often worth as much as the individual judgments themselves.
How PerspireIP supports your Cambridge litigation counsel
We work as a specialist technical-search and analysis partner to the solicitors, barristers and patent attorneys who take Cambridge disputes to the Patents Court and IPEC in London. We do not replace your legal team — we give them the element-by-element infringement reads, evidence-of-use packages and invalidity searches that make their case concrete, delivered to the court’s timetable.
- Claim construction and element-by-element infringement charts for the accused product or process
- Evidence of use assembled from teardowns, documentation, standards and configuration data
- Standard-essential patent mapping for semiconductor and connectivity claims
- Deep non-patent-literature and prior-art searching for the invalidity case tried alongside infringement
- Work scoped to IPEC’s cost-capped, streamlined track or the Patents Court’s full procedure
- Analysis coordinated with any parallel UPC action, since the UK sits outside the UPC
Whether you are a spin-out enforcing your first patent, a scale-up defending a semiconductor or biotech assertion, or in-house counsel weighing UK exposure against a parallel UPC case, we scale to fit — a single infringement read, a multi-patent campaign, or ongoing support through trial. Send us the patent number, the accused product and your key dates, and we will scope a patent infringement analysis Cambridge project within one business day.
IP Landscape & Resources in Cambridge
Key intellectual-property authorities and venues relevant to Cambridge:
- Intellectual Property Office (UK IPO) — the UK government body that grants patents and runs the patents tribunal
- Patents Court (Business and Property Courts) — the specialist High Court in London that hears larger UK patent infringement disputes
- Intellectual Property Enterprise Court (IPEC) — the cost-capped London court for smaller and simpler patent claims, suited to SMEs and spin-outs
Request a Patent Infringement Analysis in Cambridge
Request a Patent Infringement Analysis in Cambridge
Get an element-by-element infringement read and evidence-of-use package built for the London Patents Court and IPEC, with a parallel invalidity search and coordination with any UPC action, since the UK sits outside the UPC. Send us the patent number, the accused product and your key dates, and we will scope the work within one business day.
Explore related PerspireIP services: Patent Infringement Analysis · Patent Invalidation · Prior Art Litigation Search.
Frequently Asked Questions
Which court hears patent infringement cases for a Cambridge company?
There is no patent court in Cambridge. UK patent infringement is heard in London, either in the Patents Court โ part of the Business and Property Courts of the High Court at the Rolls Building โ or in the Intellectual Property Enterprise Court (IPEC) in the same building. The Patents Court takes the larger, more technical disputes; IPEC is the cost-capped, streamlined forum for smaller claims. Appeals from either court go to the Court of Appeal and then the UK Supreme Court. Unlike Germany, the English courts try infringement and validity together in one trial.
Is the UK part of the Unified Patent Court?
No. The United Kingdom is outside the Unified Patent Court and the EU unitary patent system; after Brexit it did not join the UPC. The UK designation of a European patent is litigated only in the English courts, entirely separately from any UPC action covering the participating EU states. For a Cambridge company with European markets, that means the same underlying patent can be fought in parallel in London and before the UPC, on different timetables and with the possibility of different outcomes โ neither court binds the other.
Should a Cambridge start-up litigate in IPEC or the Patents Court?
It depends on value and complexity. IPEC caps damages at ยฃ500,000 and caps recoverable costs โ historically around ยฃ50,000 for a liability trial โ with a shorter, streamlined procedure that suits spin-outs and SMEs with predictable budgets. The Patents Court has no such caps and handles the heaviest, highest-value and most technically complex disputes with full disclosure and expert evidence. A smaller Cambridge company often prefers IPEC’s cost certainty, while a bet-the-company semiconductor or biotech case may need the Patents Court.
What kinds of patents are litigated out of Silicon Fen?
The Cambridge cluster is concentrated in deep tech, so its disputes are too. Semiconductor and processor claims โ the field Arm grew from โ bring standard-essential and complex electronics questions. Life sciences and biotech, anchored by AstraZeneca, bring antibody, formulation and diagnostic claims. Software, AI and connectivity from university spin-outs add another layer. Because many Cambridge patents come out of university research, theses, journal papers and conference disclosures are frequently central both to dating infringement and to any invalidity defense.